KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Emergent BioSolutions (EBS) Current Taxes: 2012-2018

Historic Current Taxes for Emergent BioSolutions (EBS) over the last 2 years, with Dec 2018 value amounting to $4.5 million.

Emergent BioSolutions' Current Taxes was N/A to $4.5 million in Q4 2018 from the same period last year, while for Dec 2018 it was $4.5 million, marking a year-over-year change of. This contributed to the annual value of $4.5 million for FY2018, which is N/A change from last year.
Emergent BioSolutions' Current Taxes amounted to $4.5 million in FY2018, which was up 3,813.04% from $115,000 recorded in FY2012.
In the past 5 years, Emergent BioSolutions' Current Taxes registered a high of $4.5 million during FY2018, and its lowest value of $4.5 million during FY2018.
Its 1-year average for Current Taxes is $4.5 million, with a median of $4.5 million in 2018.